Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111710532 | 11171053 | 2 | F | 20120101 | 20160825 | 20150608 | 20160831 | PER | US-CELGENEUS-163-21880-12031104 | CELGENE | 51.33 | YR | F | Y | 53.35000 | KG | 20160831 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111710532 | 11171053 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 25 | MG | CAPSULES | ||||||
| 111710532 | 11171053 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 20 MILLIGRAM | U | UNKNOWN | 21880 | 25 | MG | CAPSULES | |||||
| 111710532 | 11171053 | 3 | SS | VELCADE | BORTEZOMIB | 1 | Intravenous drip | 1.8 MILLIGRAM/SQ. METER | U | 66188 | 1.8 | MG/M**2 | INJECTION | ||||||
| 111710532 | 11171053 | 4 | SS | DECADRON | DEXAMETHASONE | 1 | Oral | U | 0 | 20 | MG | UNKNOWN | /wk | ||||||
| 111710532 | 11171053 | 5 | C | BLOOD TRANSFUSION | WHOLE BLOOD | 1 | Intravenous drip | 0 | UNKNOWN | ||||||||||
| 111710532 | 11171053 | 6 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | 0 | UNKNOWN | ||||||||||
| 111710532 | 11171053 | 7 | C | ASA | ASPIRIN | 1 | Oral | 325 MILLIGRAM | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111710532 | 11171053 | 1 | Plasma cell myeloma |
| 111710532 | 11171053 | 3 | Plasma cell myeloma |
| 111710532 | 11171053 | 4 | Plasma cell myeloma |
| 111710532 | 11171053 | 5 | Product used for unknown indication |
| 111710532 | 11171053 | 6 | Product used for unknown indication |
| 111710532 | 11171053 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111710532 | 11171053 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111710532 | 11171053 | Anaemia | |
| 111710532 | 11171053 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111710532 | 11171053 | 1 | 20111223 | 20120301 | 0 | |
| 111710532 | 11171053 | 2 | 20120613 | 20120919 | 0 | |
| 111710532 | 11171053 | 3 | 20111208 | 20120305 | 0 | |
| 111710532 | 11171053 | 4 | 20111208 | 20120213 | 0 | |
| 111710532 | 11171053 | 5 | 20120101 | 0 | ||
| 111710532 | 11171053 | 6 | 20111208 | 0 | ||
| 111710532 | 11171053 | 7 | 20111208 | 0 |